Bitcoin dips under $88,000 as year-end trading thins; Strategy buy keeps crypto stocks in focus
29 December 2025
1 min read

Bitcoin dips under $88,000 as year-end trading thins; Strategy buy keeps crypto stocks in focus

NEW YORK, December 29, 2025, 10:34 ET — Regular session

  • Bitcoin slipped 0.3% to about $87,647 after briefly topping $90,000 earlier in the session.
  • Strategy disclosed a $108.8 million bitcoin purchase funded by share sales, in a filing. 1
  • Traders are watching U.S. Federal Reserve minutes on Tuesday for clues on the 2026 rate path. 2

Bitcoin edged lower in morning New York trading on Monday, slipping 0.3% to $87,647 after briefly climbing above $90,000 earlier in the session.

The muted move matters because thin year-end liquidity can exaggerate swings, with many desks operating with reduced staffing and fewer catalysts before the calendar turns. Reuters reported U.S. markets are heading into a holiday-shortened week, with trading volumes expected to be light. 3

Bitcoin is also sitting near a widely watched round-number level at $90,000, leaving traders sensitive to any shift in risk appetite tied to interest rates and macro headlines. 2

Ether, the second-largest cryptocurrency, fell 0.4% to $2,937.92.

Crypto-linked U.S. stocks were mixed. Coinbase Global shares fell 0.6%, while bitcoin proxy Strategy Inc was down 0.2% and miner Marathon Digital slipped 0.1%.

Strategy said it bought 1,229 bitcoin between December 22 and December 28 for $108.8 million, paying an average of about $88,568 per coin including fees, according to an SEC filing. 1

The company said it funded the purchases using proceeds from sales of its Class A common stock under its at-the-market (ATM) program — a facility that lets a company sell shares into the open market from time to time. The filing showed Strategy sold 663,450 shares for $108.8 million in net proceeds and had about $11.7 billion still available for issuance and sale under that common-stock ATM. 1

Broader risk sentiment was cautious, with Wall Street’s main indexes opening lower as heavyweight technology stocks gave back some of last week’s gains, Reuters reported. 3

Still, investors have largely kept the focus on the outlook for U.S. interest rates. Fidelity International multi-asset portfolio manager Becky Qin said, “We’re not seeing runaway inflation risk,” adding she still sees room for the Fed to cut. 2

The next near-term macro test is the release of minutes from the Fed’s latest meeting on Tuesday, after the central bank cut rates this month and markets continued to price further easing in 2026, Reuters reported. 2

For crypto traders, the intraday range underscored the tug-of-war near key levels: bitcoin’s session high was $90,247 and the low was $86,780.

Bitcoin remains far below its October peak, when it hit a record above $126,000, a drawdown that has kept hedge demand and positioning sensitive to macro swings. 4

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Barrick slides as gold cools from record highs; Fed minutes in focus
Previous Story

Barrick slides as gold cools from record highs; Fed minutes in focus

New SEC filings reveal who just trimmed JPMorgan stock
Next Story

New SEC filings reveal who just trimmed JPMorgan stock

Go toTop